GGrantIndex
← Leaderboards

Xiufeng Henry Wan

University Of Missouri-Columbia

$11,299,838
Attributed
$13,938,116
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,938,116 · 8

By mechanism

R01$12,260,163 · 4
R21$839,681 · 2
R15$425,359 · 1
RC1$412,913 · 1

Top collaborators

Most similar at University Of Missouri-Columbia

Same institution · by research overlap

Others in their field

Top investigators on “Mutation

Research focus

MutationInfluenza A VirusInfluenzavirusAffectVirusPandemic DiseaseInfluenza Virus VaccineVariantBaseVaccinesAntibodiesInfluenza A Virus, H1n1 SubtypeUniversal Influenza VaccineResponseInfluenza OutbreakSpecificityAntigensAntigenic VariationGenomicsMolecularHemagglutininInfluenzaImmunitySeasons

Grant awards (28)

Selecting HA glycosylation for improved vaccine responses$758,441
R01 · FY2025 · AI
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines$725,339
R01 · FY2025 · AI · contact PI
Selecting HA glycosylation for improved vaccine responses$792,434
R01 · FY2024 · AI
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines$722,061
R01 · FY2024 · AI · contact PI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants$553,124
R01 · FY2024 · AI · contact PI
Selecting HA glycosylation for improved vaccine responses$792,434
R01 · FY2023 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants$553,124
R01 · FY2023 · AI · contact PI
Selecting HA glycosylation for improved vaccine responses$792,434
R01 · FY2022 · AI
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines$720,420
R01 · FY2022 · AI · contact PI
Selecting HA glycosylation for improved vaccine responses$821,674
R01 · FY2021 · AI
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines$727,200
R01 · FY2021 · AI · contact PI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants$553,124
R01 · FY2021 · AI · contact PI
Influenza host specific glycan motif identification through systems biology$199,831
R21 · FY2021 · AI · contact PI
Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines$758,514
R01 · FY2020 · AI · contact PI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants$553,124
R01 · FY2020 · AI · contact PI
Influenza host specific glycan motif identification through systems biology$239,725
R21 · FY2020 · AI · contact PI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants$566,874
R01 · FY2019 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$224,899
R01 · FY2019 · AI · contact PI
Risk Assessment of Influenza A viruses$213,077
R21 · FY2019 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$147,704
R01 · FY2019 · AI · contact PI
Risk Assessment of Influenza A Viruses$5,173
R21 · FY2019 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$372,603
R01 · FY2018 · AI · contact PI
Risk Assessment of Influenza A Viruses$181,875
R21 · FY2018 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$372,603
R01 · FY2017 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$370,329
R01 · FY2016 · AI · contact PI
Genome Based Influenza Vaccine Strain Selection using Machine Learning$381,704
R01 · FY2015 · AI · contact PI
Glycan receptors specific for canine influenza infection$425,359
R15 · FY2013 · AI · contact PI
Prediction of influenza antigenic variants using a novel sparse multitask learnin$412,913
RC1 · FY2010 · AI · contact PI